![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Brioli, Annamaria 
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia, Bd. 38: S. 1072-1080
[PDF, 1MB]
Efficace, Fabio ORCID: https://orcid.org/0000-0002-5065-5166; Mahon, Francois-Xavier; Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823; Piciocchi, Alfonso ORCID: https://orcid.org/0000-0001-8648-885X; Cipriani, Marta ORCID: https://orcid.org/0000-0001-6159-8059; Nicolini, Franck E.; Mayer, Jiri; Zackova, Daniela ORCID: https://orcid.org/0000-0001-9802-8148; Janssen, Jeroen J. W. M. ORCID: https://orcid.org/0000-0001-9567-1955; Panayiotidis, Panayiotis; Vestergaard, Hanne; Koskenvesa, Perttu; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Martinez-Lopez, Joaquin; Olsson-Strömberg, Ulla; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Berger, Marc G.; Etienne, Gabriel; Klamova, Hana ORCID: https://orcid.org/0009-0000-5020-7040; Faber, Edgar; Rousselot, Philippe; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690 und Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2024):
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
In: Leukemia, Bd. 38, Nr. 8: S. 1722-1730
ORCID: https://orcid.org/0000-0002-5065-5166; Mahon, Francois-Xavier; Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823; Piciocchi, Alfonso ORCID: https://orcid.org/0000-0001-8648-885X; Cipriani, Marta ORCID: https://orcid.org/0000-0001-6159-8059; Nicolini, Franck E.; Mayer, Jiri; Zackova, Daniela ORCID: https://orcid.org/0000-0001-9802-8148; Janssen, Jeroen J. W. M. ORCID: https://orcid.org/0000-0001-9567-1955; Panayiotidis, Panayiotis; Vestergaard, Hanne; Koskenvesa, Perttu; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Martinez-Lopez, Joaquin; Olsson-Strömberg, Ulla; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Berger, Marc G.; Etienne, Gabriel; Klamova, Hana ORCID: https://orcid.org/0009-0000-5020-7040; Faber, Edgar; Rousselot, Philippe; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690 und Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2024):
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
In: Leukemia, Bd. 38, Nr. 8: S. 1722-1730
Machova Polakova, Katerina ORCID: https://orcid.org/0000-0002-7398-5555; Albeer, Ali ORCID: https://orcid.org/0009-0002-1746-1260; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola; Fabarius, Alice; Klamova, Hana; Spiess, Birgit; Waller, Cornelius F. ORCID: https://orcid.org/0000-0002-5777-0212; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Dengler, Jolanta; Kunzmann, Volker; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Belohlavkova, Petra; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Faber, Edgar; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Zackova, Daniela ORCID: https://orcid.org/0000-0001-9802-8148; Panayiotidis, Panayiotis; Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Kamińska, Magdalena; Płonka, Magdalena; Szczepanek, Elżbieta; Szarejko, Monika; Bober, Grażyna; Hus, Iwona; Grzybowska-Izydorczyk, Olga; Wasilewska, Ewa; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Niesiobędzka-Krężel, Joanna; Giannopoulos, Krzysztof; Mahon, Francois X.; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785 und Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690
(2023):
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
In: Leukemia, Bd. 38: S. 318-325
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-7398-5555; Albeer, Ali ORCID: https://orcid.org/0009-0002-1746-1260; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola; Fabarius, Alice; Klamova, Hana; Spiess, Birgit; Waller, Cornelius F. ORCID: https://orcid.org/0000-0002-5777-0212; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Dengler, Jolanta; Kunzmann, Volker; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Belohlavkova, Petra; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Faber, Edgar; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Zackova, Daniela ORCID: https://orcid.org/0000-0001-9802-8148; Panayiotidis, Panayiotis; Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Kamińska, Magdalena; Płonka, Magdalena; Szczepanek, Elżbieta; Szarejko, Monika; Bober, Grażyna; Hus, Iwona; Grzybowska-Izydorczyk, Olga; Wasilewska, Ewa; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Niesiobędzka-Krężel, Joanna; Giannopoulos, Krzysztof; Mahon, Francois X.; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785 und Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690
(2023):
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
In: Leukemia, Bd. 38: S. 318-325
[PDF, 1MB]
Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Strömberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas und Pfirrmann, Markus
(November 2019):
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
In: American Journal of Hematology, Bd. 94, Nr. 11: S. 1236-1243
[PDF, 1MB]